Healthcare Stocks

Business

Mineralys Therapeutics Submits New Drug Application for Hypertension Treatment Lorundrostat, Backed by Strong Clinical Data

Clinical-stage biopharma Mineralys Therapeutics has filed its New Drug Application for lorundrostat, a potential treatment for resistant hypertension, following positive results from multiple trials. The move positions the company for a potential 2026 market entry and has drawn upgraded price targets from analysts.

Jan 30, 2026

Business

DigitalOcean Soars as 'Clawdbot' AI Assistant Drives Analyst Optimism and Price Target Hikes

Bank of America leads a wave of analyst upgrades for DigitalOcean, citing the viral success of its AI agent 'Clawdbot' and the company's strategic positioning in the burgeoning agentic AI market for developers.

Jan 30, 2026

Business

Bango's Turnaround: From Losses to Profitability as Capital Efficiency Rises

The UK-based payments technology firm Bango (LON:BGO) is showing early signs of a financial transformation, breaking into profitability and increasing its capital deployment. While its return on capital remains below the software industry average, the underlying trend suggests a company in the midst of a strategic pivot.

Jan 30, 2026

Business

Stryker Caps Record Year with Strong Q4, Bullish on 2026 Despite Market Headwinds

The medical technology giant reports double-digit organic sales growth for the fourth consecutive year, driven by its Mako robotic system and strategic leadership shifts, while navigating tariffs and a shifting competitive landscape.

Jan 30, 2026

Business

Meritage Homes Stock: A Deep Value Play or Market Skepticism?

Meritage Homes shares have lagged peers over the past year, but a detailed valuation analysis suggests a significant gap between its current price and estimated intrinsic value. We examine the DCF and P/E metrics fueling the debate.

Jan 30, 2026

Business

Thyssenkrupp Shares Soar 220%: Is the Rally Justified or Has the Train Left the Station?

Thyssenkrupp AG's stock has skyrocketed over the past year, leaving investors to grapple with a critical question: does the German industrial giant still offer value, or is it now overhyped? We delve into the valuation metrics, market context, and expert perspectives to separate signal from noise.

Jan 30, 2026

Business

KKR's Stock Slump: A Buying Opportunity or a Valuation Trap?

KKR & Co.'s shares have retreated over 10% this year, prompting investors to question if the alternative asset manager's long-term growth story justifies its premium valuation. We analyze key metrics and expert narratives to gauge the stock's true appeal.

Jan 30, 2026

Business

Centurion Corp (SGX:OU8): A Closer Look at the Singapore Stock Gaining Investor Attention

Amidst a market often captivated by speculative narratives, Centurion Corporation stands out with a track record of robust profit growth and significant insider confidence. We examine the key metrics and signals making this industrial accommodation provider a name to watch.

Jan 30, 2026

Business

Wee Hur Holdings' Stock Surge: A Closer Look at the Financial Drivers Behind the 24% Rally

Shares of Singapore's Wee Hur Holdings Ltd. (SGX:E3B) have climbed 24% in the past quarter, outpacing broader market trends. While its Return on Equity appears modest, aggressive reinvestment of profits and a strategic shift in its business model may be fueling investor optimism and the recent price momentum.

Jan 30, 2026

Business

HSBC Upgrades Grab to Buy, Sees Over 45% Upside as Southeast Asia's Super App Gains Traction

HSBC has upgraded Grab Holdings from Hold to Buy with a $6.20 price target, citing attractive valuation and intact growth drivers. The stock, already on some 'best buy' lists, has surged nearly 5% this week, with Wall Street analysts forecasting significant upside ahead of its Q4 earnings report.

Jan 30, 2026

Business

P&G Bolsters Health Portfolio with Acquisition of Digestive Wellness Brand Wonderbelly

Consumer goods giant Procter & Gamble has agreed to acquire Wonderbelly, a fast-growing brand in the 'free-from' digestive health space, signaling a deeper push into the lucrative wellness category and a bid to attract younger, label-conscious consumers.

Jan 30, 2026

Business

BD Strikes Waters Deal and Advances Medical Plastics Recycling in Strategic Overhaul

Becton Dickinson announces a major spin-off of its Biosciences unit to combine with Waters Corporation, alongside a successful pilot to recycle polystyrene labware, signaling a dual push towards portfolio focus and sustainability.

Jan 30, 2026

Business

Ally Financial's Valuation Puzzle: Is the Stock a Bargain After Recent Volatility?

Ally Financial shares have experienced significant price swings, leaving investors to question if the current level around $42.96 presents a buying opportunity. While short-term performance has been mixed, our analysis suggests the stock may be trading below its intrinsic value.

Jan 30, 2026

Business

Hartford Financial (HIG): A Deep Value Play After Years of Stellar Gains?

Despite a powerful multi-year rally, new analysis suggests The Hartford's stock may still be trading at a significant discount. We examine the valuation metrics and market sentiment surrounding the insurance giant.

Jan 30, 2026

Business

Beyond the Headlines: Unearthing Small-Cap Opportunities in Asia's Volatile 2026 Markets

Amidst a complex backdrop of economic crosscurrents and geopolitical tensions, a select group of small-cap companies across Asia are demonstrating remarkable resilience and growth potential. We analyze three standout names from Singapore and China that are navigating the volatility with strong fundamentals.

Jan 30, 2026

Business

Medicare Advantage Funding Freeze Puts Clover Health's Profitability in the Spotlight

Proposed flat payment rates for 2027 by CMS intensify margin pressures on Medicare Advantage insurers like Clover Health, raising investor concerns about cost management and growth prospects in a tightening regulatory landscape.

Jan 30, 2026

Business

Beyond the Headlines: Three Middle Eastern Small-Caps Defying Geopolitical Turbulence

As regional tensions weigh on major Gulf indices, a closer look reveals resilient investment opportunities among smaller, financially sound companies. From energy giants to niche manufacturers, these picks highlight value where many fear to tread.

Jan 30, 2026

Business

Thai Beverage's Five-Year Slump: Shareholders Grapple with 29% Loss Amid Market Outperformance

Despite modest earnings growth, Thai Beverage (SGX:Y92) has seen its share price tumble 40% over five years, leaving long-term investors with a significant total return deficit. We examine the disconnect between fundamentals and market sentiment.

Jan 30, 2026

Business

Celestica Shares Tumble 13% Post-Earnings as AI Hype Fails to Lift Stock

Despite reporting a near-doubling of annual net income and raising its 2026 outlook, electronics manufacturer Celestica saw its shares drop sharply Thursday as the market judged its stellar results to be already reflected in the price.

Jan 30, 2026

Business

Applied Optoelectronics Shares Tumble 12.5% as Investors Cash In on Eight-Year High

Shares of Applied Optoelectronics (AAOI) retreated sharply Thursday, shedding 12.5% as a wave of profit-taking followed the stock's surge to its highest level in nearly eight years. The pullback comes despite analyst optimism around the company's role in powering AI data centers.

Jan 30, 2026